187 results on '"Zhou, Suna"'
Search Results
2. Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy
3. CT-based different regions of interest radiomics analysis for acute radiation pneumonitis in patients with locally advanced NSCLC after chemoradiotherapy
4. Current state, challenges, and future perspective of adaptive radiotherapy: A narrative review of nasopharyngeal carcinoma
5. Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy
6. CT-based radiomics nomogram may predict who can benefit from adaptive radiotherapy in patients with local advanced-NSCLC patients
7. Retraction Note: The Noncytotoxic Dose of Sorafenib Sensitizes Bel-7402/5-FU Cells to 5-FU by Down-Regulating 5-FU-Induced Nrf2 Expression
8. The role of autophagy in initiation, progression, TME modification, diagnosis, and treatment of esophageal cancers
9. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer
10. The role of epithelial-mesenchymal transition in regulating radioresistance
11. Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
12. MicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction]
13. Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies
14. MicroRNA-381 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma by Targeting X-Linked Inhibitor of Apoptosis Protein [Retraction]
15. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy
16. The critical components for effective adaptive radiotherapy in patients with unresectable non-small-cell lung cancer: who, when and how
17. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma
18. Nrf2 is a potential therapeutic target in radioresistance in human cancer
19. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration
20. Corrigendum: Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
21. Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
22. # 1722 Role of miR-150 and its potential targets in pathogenesis of IBD
23. # 1700 Evaluation of synchronized chemoradiation in 48 elder advanced gastric adenocarcinoma cases with celiac lymph node metastasis
24. # 1627 miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway
25. Microrna-381 regulates radiosensitivity in esophageal squamous cell carcinoma: P-656
26. RETRACTED ARTICLE: The Noncytotoxic Dose of Sorafenib Sensitizes Bel-7402/5-FU Cells to 5-FU by Down-Regulating 5-FU-Induced Nrf2 Expression
27. Mechanisms of Apoptin-induced cell death
28. Adaptive intensity-modulated radiotherapy with simultaneous integrated boost for stage III non-small cell lung cancer: Is a routine adaptation beneficial?
29. Evaluation of Gallbladder Lipid Level During Carcinogenesis by an Infrared Spectroscopic Method
30. FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L
31. Corrigendum: CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma
32. GBP1 Facilitates Indoleamine 2,3-Dioxygenase Extracellular Secretion to Promote the Malignant Progression of Lung Cancer
33. Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
34. USP46 Inhibits Cell Proliferation in Lung Cancer through PHLPP1/AKT Pathway
35. A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma
36. CDKL3 Targets ATG5 to Promote Carcinogenesis of Esophageal Squamous Cell Carcinoma
37. Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma
38. Endostar improved efficacy of concurrent chemoradiotherapy with vinorelbine plus carboplatin in locally advanced lung squamous cell carcinoma patients with high serum Lp(a) concentration
39. Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2
40. Abstract 2054: A novel Bcl-2/Bcl-XL inhibitor APG-1252-12A as a potential therapeutic strategy for gastric carcinoma
41. Abstract 3958: FAK inhibition reduces tumor infiltration of Tregs via restricting CCL5 release and boosts the present therapeutic regimen for BRAFV600E-mutated colorectal carcinoma
42. Abstract 2061: A novel small molecule inhibitor of MDM2-p53 (APG-115) has antitumor activity in gastric adenocarcinoma
43. A Novel Small Molecule Inhibitor of MDM2-p53 (APG-115) Has Antitumor Activity in Gastric Adenocarcinoma
44. Smac Mimetic APG-1387 Has Synergistic Effect with anti-PD1 Antibody via Increasing NK Cells Recruitment by Inducing Multiple Cytokines from Tumor Cells
45. FAK Inhibition Reduces Tumor Infiltration of Tregs via Restricting CCL5 Release and Boosts the Combination Therapy for BRAF V600E Mutant Colorectal Carcinoma
46. Increased CDKL3 expression predicts poor prognosis and enhances malignant phenotypes in esophageal squamous cell carcinoma
47. Prostacyclin administration as a beneficial supplement to the conventional cancer chemotherapy
48. Tumor-targeted delivery of TAT-Apoptin fusion gene using Escherichia coli Nissle 1917 to colorectal cancer
49. RETRACTED ARTICLE: MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein
50. miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.